Literature DB >> 25836587

The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination.

D Inoue1, K Nishimura1, H Kozuka-Hata2, M Oyama2, T Kitamura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25836587     DOI： 10.1038/leu.2015.90

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  A common ancestry for BAP1 and Uch37 regulators.

Authors:  Luis Sanchez-Pulido; Lesheng Kong; Chris P Ponting
Journal:  Bioinformatics       Date:  2012-05-29       Impact factor: 6.937

2.  Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.

Authors:  Felicitas Thol; Inna Friesen; Frederik Damm; Haiyang Yun; Eva M Weissinger; Jürgen Krauter; Katharina Wagner; Anuhar Chaturvedi; Amit Sharma; Martin Wichmann; Gudrun Göhring; Christiane Schumann; Gesine Bug; Oliver Ottmann; Wolf-Karsten Hofmann; Brigitte Schlegelberger; Michael Heuser; Arnold Ganser
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

3.  Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.

Authors:  Jiapeng Wang; Zhaomin Li; Yongzheng He; Feng Pan; Shi Chen; Steven Rhodes; Lihn Nguyen; Jin Yuan; Li Jiang; Xianlin Yang; Ophelia Weeks; Ziyue Liu; Jiehao Zhou; Hongyu Ni; Chen-Leng Cai; Mingjiang Xu; Feng-Chun Yang
Journal:  Blood       Date:  2013-11-19       Impact factor: 22.113

4.  Systematic and quantitative assessment of the ubiquitin-modified proteome.

Authors:  Woong Kim; Eric J Bennett; Edward L Huttlin; Ailan Guo; Jing Li; Anthony Possemato; Mathew E Sowa; Ramin Rad; John Rush; Michael J Comb; J Wade Harper; Steven P Gygi
Journal:  Mol Cell       Date:  2011-09-08       Impact factor: 17.970

5.  Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.

Authors:  Daichi Inoue; Jiro Kitaura; Katsuhiro Togami; Koutarou Nishimura; Yutaka Enomoto; Tomoyuki Uchida; Yuki Kagiyama; Kimihito Cojin Kawabata; Fumio Nakahara; Kumi Izawa; Toshihiko Oki; Akie Maehara; Masamichi Isobe; Akiho Tsuchiya; Yuka Harada; Hironori Harada; Takahiro Ochiya; Hiroyuki Aburatani; Hiroshi Kimura; Felicitas Thol; Michael Heuser; Ross L Levine; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

6.  Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia.

Authors:  Cynthia L Fisher; Nicolas Pineault; Christy Brookes; Cheryl D Helgason; Hideaki Ohta; Caroline Bodner; Jay L Hess; R Keith Humphries; Hugh W Brock
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

Review 7.  Histone H2B monoubiquitination: roles to play in human malignancy.

Authors:  Alexander J Cole; Roderick Clifton-Bligh; Deborah J Marsh
Journal:  Endocr Relat Cancer       Date:  2014-06-02       Impact factor: 5.678

8.  Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor.

Authors:  Goedele N Maertens; Selma El Messaoudi-Aubert; Sarah Elderkin; Kevin Hiom; Gordon Peters
Journal:  EMBO J       Date:  2010-07-02       Impact factor: 11.598

9.  The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.

Authors:  Min Sup Song; Leonardo Salmena; Arkaitz Carracedo; Ainara Egia; Francesco Lo-Coco; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2008-08-20       Impact factor: 49.962

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
View more
  9 in total

1.  Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.

Authors:  Xue Li; Lingmei Kong; Qihong Yang; Aizhu Duan; Xiaoman Ju; Bicheng Cai; Lin Chen; Tao An; Yan Li
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

Review 2.  The Role of Additional Sex Combs-Like Proteins in Cancer.

Authors:  Jean-Baptiste Micol; Omar Abdel-Wahab
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

3.  Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates.

Authors:  Peng Zhang; Zizhen Chen; Rong Li; Ying Guo; Hui Shi; Jie Bai; Hui Yang; Mengyao Sheng; Zhaomin Li; Zhuo Li; Jianping Li; Shi Chen; Weiping Yuan; Tao Cheng; Mingjiang Xu; Yuan Zhou; Feng-Chun Yang
Journal:  Cell Discov       Date:  2018-01-23       Impact factor: 10.849

Review 4.  The Gentle Side of the UPS: Ubiquitin-Proteasome System and the Regulation of the Myogenic Program.

Authors:  Hugo C Olguín
Journal:  Front Cell Dev Biol       Date:  2022-01-20

5.  A De Novo Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as Opitz-C: Similarities Between Schaaf-Yang and Opitz-C Syndromes.

Authors:  Roser Urreizti; Anna Maria Cueto-Gonzalez; Héctor Franco-Valls; Sílvia Mort-Farre; Neus Roca-Ayats; Julia Ponomarenko; Luca Cozzuto; Carlos Company; Mattia Bosio; Stephan Ossowski; Magda Montfort; Jochen Hecht; Eduardo F Tizzano; Bru Cormand; Lluïsa Vilageliu; John M Opitz; Giovanni Neri; Daniel Grinberg; Susana Balcells
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

6.  Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.

Authors:  Seemana Bhattacharya; Dipankar Chakraborty; Malini Basu; Mrinal K Ghosh
Journal:  Signal Transduct Target Ther       Date:  2018-06-29

7.  Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.

Authors:  Salima Daou; Haithem Barbour; Oumaima Ahmed; Louis Masclef; Caroline Baril; Nadine Sen Nkwe; Daméhan Tchelougou; Maxime Uriarte; Eric Bonneil; Derek Ceccarelli; Nazar Mashtalir; Mika Tanji; Jean-Yves Masson; Pierre Thibault; Frank Sicheri; Haining Yang; Michele Carbone; Marc Therrien; El Bachir Affar
Journal:  Nat Commun       Date:  2018-10-22       Impact factor: 14.919

8.  Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.

Authors:  Shuhei Asada; Susumu Goyama; Daichi Inoue; Shiori Shikata; Reina Takeda; Tsuyoshi Fukushima; Taishi Yonezawa; Takeshi Fujino; Yasutaka Hayashi; Kimihito Cojin Kawabata; Tomofusa Fukuyama; Yosuke Tanaka; Akihiko Yokoyama; Satoshi Yamazaki; Hiroko Kozuka-Hata; Masaaki Oyama; Shinya Kojima; Masahito Kawazu; Hiroyuki Mano; Toshio Kitamura
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919

9.  USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia.

Authors:  Huizhuang Shan; Xiangyun Li; Xinhua Xiao; Yuting Dai; Jinyan Huang; Junjun Song; Meng Liu; Li Yang; Hu Lei; Yin Tong; Li Zhou; Hanzhang Xu; Yingli Wu
Journal:  Signal Transduct Target Ther       Date:  2018-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.